DalsnaFinance

Consano Bio Highlights Scientific Advisory Board for C-1101, a Potential First-in-Class, Non-Opioid Therapy in Development for Chronic Sciatica

Markets PR Newswire By PR Newswire 29 Jun 2026 12:33 1 min read
Consano Bio Highlights Scientific Advisory Board for C-1101, a Potential First-in-Class, Non-Opioid Therapy in Development for Chronic Sciatica

Board brings deep expertise in pain medicine, regulatory strategy, biologics manufacturing, and hematological research to guide the company's first-in-class program Advisory support includes former U.S. Surgeon General Jerome Adams, M.D., MPH, and interventional orthopedics pioneer...

Board brings deep expertise in pain medicine, regulatory strategy, biologics manufacturing, and hematological research to guide the company's first-in-class program Advisory support includes former U.S. Surgeon General Jerome Adams, M.D., MPH, and interventional orthopedics pioneer...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.